TRANS (+/-) (4-(4-METHYLPHENYL)PYRROLIDIN-3-YL)CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 1g

3-Methyl-1-{4-[4-(propan-2-yl)benzenesulfonyl]phenyl}-1H-pyrazol-5-amine, 97%, 250mg

4,8-Dibromobenzo[1,2-c:4,5-c']bis([1,2,5]thiadiazole), 95.0%, 100mg

3-BROMO-1-METHYL-1H-INDAZOLE-6-CARBOXYLIC ACID, 95.0%, 100mg

Ytterbium (III) trifluoromethanesulphonate, 90.0%, 5g

Methyl 2-(Cyanomethyl)benzoate>98.0%(GC)5g

4-(2-Bromophenyl)-1h-pyrazole, 98%, 250mg

4-Bromo-2-(difluoromethyl)pyridine, 95.0%, 10g

7-Bromo-5-fluoro-1H-indazole, 95.0%, 100mg

(S)-5-(Aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1H-imidazole-2(3H)-thione hydrochloride, 95.0%, 1mg

3-(Benzylamino)-4-nitrobenzoic acid, 96.0%, 1g

Bis(chloromethyl)dimethylsilane, 97.0%, 10g

2-(2-Bromophenyl)piperazine, 95%, 1g